Concepedia

Daniela Passeri

DP

31

Publications

1.2K

Citations

19

H-Index

2005

Active since

Affiliations

University of Rome Tor Vergata(Current)

Sapienza University of Rome

University of Perugia

University of Campania "Luigi Vanvitelli"

Sigma Tau (Italy)

Daniela Passeri is an author at University of Rome Tor Vergata specializing in medicine, pharmacology, and natural sciences.

ORCID

Top concepts

Publications per year

2005–2022

31

Publications

31

Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 Agonist

Giovanni Rizzo, Daniela Passeri, Francesca Franco et al. · Molecular Pharmacology · 2010 · 182 citations · Full text

PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy

Erica Salvati, Marco Scarsella, Manuela Porru et al. · Oncogene · 2010 · 122 citations · Full text

, , +5

Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure–Activity Relationship, X-ray Crystal Structure, and Anticancer Activity

S. Moniot, Mariantonietta Forgione, Alessia Lucidi et al. · Journal of Medicinal Chemistry · 2017 · 103 citations · Full text

The Methyl Transferase PRMT1 Functions as Co-Activator of Farnesoid X Receptor (FXR)/9-cis Retinoid X Receptor and Regulates Transcription of FXR Responsive Genes

Giovanni Rizzo, Barbara Renga, Elisabetta Antonelli et al. · Molecular Pharmacology · 2005 · 76 citations

Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders

Roberto Pellicciari, Daniela Passeri, Francesca Franco et al. · Journal of Medicinal Chemistry · 2016 · 60 citations · Full text

, , +22

Rows per page

1–5 of 31